tert-Butyl 4-amino-2,2-dimethylpiperidine-1-carboxylate, 95.0%, 1g

1,2-DIHYDRO-2,6-NAPHTHYRIDIN-3(4H)-ONE, 95.0%, 250mg

Methyl 4-(3-Bromopropyl)benzoate, 95.0%, 5g

Recipiente de cristalización ROTILABO® sin pico, 150 ml, 80 mm, 10 Unidad(es)

3-(METHOXYMETHOXY)PROPANENITRILE, 95.0%, 5g

1-Phenethyl-4-(3-phenyl-propyl)-piperidine, 25g

4-(Trifluoromethyl)cyclohexylamine, 98.0%, 100mg

3-(chloromethyl)-5-ethyl-1H-1,2,4-triazole hydrochloride, 95.0%, 5g

8-tert-butyl-4-(3,4-difluorobenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

7-(Trifluoromethyl)isoquinolin-3-amine, 95+%, 1g

tert-Butyl (5-nitropyridin-2-yl)carbamate, 95.0%, 250mg

(5-(3-Chlorophenyl)pyridin-3-yl)methanol, 95+%, 1g

2-(4-Bromobenzyl)isoindoline-1,3-dione, 95.0%, 1g